Cisatracurium Besylate Injection
Product Images NDC 31722-312

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 31722-312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cisatracurium-artwork1 (Cisatracurium Artwork1)

Label for Cisatracurium Besylate Injection, USP, 10 mg/5 mL (2 mg/mL) intravenous injection, single-dose vial, by Camber Pharmaceuticals Inc. The label includes a warning that it is a paralyzing agent causing respiratory arrest and storage instructions to refrigerate at 2° to 8°C, protect from light, and use within 21 days once at room temperature. It also states the product is sterile, nonpyrogenic, and preservative free.*

FDA Label Image

Cisatracurium-artwork2 (Cisatracurium Artwork2)

Carton label for Cisatracurium Besylate Injection USP 10 mg/5 mL (2 mg/mL) intravenous injection by Camber Pharmaceuticals Inc. The package contains 10 single-dose vials of 5 mL each. The label highlights a warning that the product is a paralyzing agent, benzyl alcohol free and preservative free, for intravenous use only, and Rx only.*

FDA Label Image

Cisatracurium-artwork4 (Cisatracurium Artwork4)

Packaging label for Cisatracurium Besylate Injection, USP 20 mg/10 mL (2 mg/mL) by Camber Pharmaceuticals Inc. The label indicates multiple-dose vials, 10 x 10 mL. It highlights the product as a paralyzing agent with 0.9% benzyl alcohol as a preservative, intended for intravenous injection. Label includes NDC 31722-314-10 and storage instructions.*

FDA Label Image

Cisatracurium-artwork5 (Cisatracurium Artwork5)

Label for Cisatracurium Besylate Injection, USP, 10 mg/mL (200 mg/20 mL) intravenous injection, supplied by Camber Pharmaceuticals Inc. This single-dose vial contains 20 mL. The label includes warnings about paralysis and respiratory arrest, storage instructions at 2° to 8°C, and notes that the product is sterile, nonpyrogenic, benzyl alcohol free, and preservative free. Manufacturer information and barcode are also present.*

FDA Label Image

Cisatracurium-artwork6 (Cisatracurium Artwork6)

Packaging label for Cisatracurium Besylate Injection, USP 200 mg/20 mL (10 mg/mL) by Camber Pharmaceuticals Inc. The label states the product is for intravenous injection, benzyl alcohol free and preservative free. It includes warnings that it is a paralyzing agent for ICU use only. The carton contains 10 single-dose 20 mL vials and also provides storage instructions and manufacturing information.*

FDA Label Image

Cisatracurium-fig1 (Cisatracurium Fig1)

A scatter plot chart displaying data points centered near the origin with axes labeled as MAP (mean arterial pressure) on the horizontal axis and HR (heart rate) on the vertical axis. Both axes range from -60% to +60%, illustrating percentage changes in MAP and HR.*

FDA Label Image

Cisatracurium-fig2 (Cisatracurium Fig2)

Scatter plot showing changes in heart rate (HR) and mean arterial pressure (MAP) with percentage scales from -60% to +60% on both axes. The chart depicts individual data points clustered near the origin, indicating minimal variation in HR and MAP values.*

FDA Label Image

Cisatracurium-str (Cisatracurium Str)

Chemical structure of Cisatracurium Besylate showing its molecular configuration with distinct methoxy and quaternary ammonium groups, including the besylate counterion.*

FDA Label Image

Cisatracurium-artwork3 (Cistracurium Artwork3)

Label for Cisatracurium Besylate Injection USP 2 mg/mL (20 mg/10 mL) multiple-dose vial by Camber Pharmaceuticals Inc. The label includes warnings about paralytic effects and respiratory arrest, storage instructions to refrigerate at 2° to 8°C, and details on the preservative used. It states the product is sterile, nonpyrogenic, for intravenous injection, and includes manufacturer and contact information.*

FDA Label Image

Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.